CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9374463.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Natural killer T (NKT) lymphocytes express an invariant T cell antigen receptor (TCR) encoded by the Valpha14 and Jalpha281 gene segments. A glycosylceramide-containing alpha-anomeric sugar with a longer fatty acyl chain (C26) and sphingosine base (C18) was identified as a ligand for this TCR. Glycosylceramide-mediated proliferative responses of Valpha14 NKT cells were abrogated by treatment with chloroquine-concanamycin A or by monoclonal antibodies against CD1d/Vbeta8, CD40/CD40L, or B7/CTLA-4/CD28, but not by interference with the function of a transporter-associated protein. Thus, this lymphocyte shares distinct recognition systems with either T or NK cells.
Medical subject headings
- Antigens, CD1
- Ceramides
- Cerebrosides
- Killer Cells, Natural
- Lymphocyte Activation
- Receptors, Antigen, T-Cell, alpha-beta
- T-Lymphocyte Subsets